Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: ValuEngine, Inc.
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Intermolecular Inc Issues Q2 2013 Guidance; Revenue Guidance Below Analysts' Estimates


Thursday, 25 Apr 2013 04:10pm EDT 

Intermolecular Inc announced that for the second quarter of 2013, it expects revenue in the range of $16.0 million to $17.0 million, revenue projection includes $12.3 million from reported backlog as of March 31, 2013, and also takes into account the expected re-alignment of the Company's CDP program with GLOBALFOUNDRIES and Non-GAAP net income, excluding stock-based compensation expense, between a non-GAAP net loss of ($1.0) million and breakeven, or between ($0.02) per share to $0.00 per share (EPS). According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of $18.5 million and EPS of $0.00 for the second quarter of 2013. 

Company Quote

1.98
-0.02 -1.00%
24 Dec 2014